Covered recipient · General Payments record
JULIE ANNE MONROE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,297.74
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $475.22 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $181.98 | 12 |
| Novo Nordisk AS | $74.40 | 4 |
| Lilly USA, LLC | $54.50 | 3 |
| Otsuka America Pharmaceutical, Inc. | $47.98 | 3 |
| Amgen Inc. | $34.09 | 2 |
| Astellas Pharma US Inc | $28.97 | 2 |
| Acerta Pharma LLC | $18.92 | 1 |
| PFIZER INC. | $18.66 | 1 |
| Lundbeck LLC | $15.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.16 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056476 | CMS |
| ABBVIE INC. | $7.21 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056478 | CMS |
| ABBVIE INC. | $19.90 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056480 | CMS |
| ABBVIE INC. | $12.54 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056482 | CMS |
| ABBVIE INC. | $5.34 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056484 | CMS |
| ABBVIE INC. | $12.63 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056486 | CMS |
| ABBVIE INC. | $10.15 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056488 | CMS |
| ABBVIE INC. | $32.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056490 | CMS |
| ABBVIE INC. | $6.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056492 | CMS |
| ABBVIE INC. | $11.68 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056494 | CMS |
| ABBVIE INC. | $20.93 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056496 | CMS |
| ABBVIE INC. | $25.98 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105056498 | CMS |
| Amgen Inc. | $17.35 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117331186 | CMS |
| Amgen Inc. | $16.74 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117331188 | CMS |
| Astellas Pharma US Inc | $13.20 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139367763 | CMS |
| Astellas Pharma US Inc | $15.77 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268370 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.92 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104250957 | CMS |
| Lilly USA, LLC | $20.45 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135086384 | CMS |
| Lilly USA, LLC | $18.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135100688 | CMS |
| Lilly USA, LLC | $15.09 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135100686 | CMS |
| Lundbeck LLC | $15.72 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145947666 | CMS |
| Novo Nordisk Inc | $18.86 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097347977 | CMS |
| Novo Nordisk Inc | $20.44 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097244630 | CMS |
| Novo Nordisk Inc | $19.98 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097154930 | CMS |
| Novo Nordisk Inc | $15.12 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096994843 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.94 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118944857 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.18 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118944859 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.86 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118944861 | CMS |
| PFIZER INC. | $18.66 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131417395 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.